Literature DB >> 27117390

The importance of DNA methylation in prostate cancer development.

Charles E Massie1, Ian G Mills2, Andy G Lynch3.   

Abstract

After briefly reviewing the nature of DNA methylation, its general role in cancer and the tools available to interrogate it, we consider the literature surrounding DNA methylation as relating to prostate cancer. Specific consideration is given to recurrent alterations. A list of frequently reported genes is synthesized from 17 studies that have reported on methylation changes in malignant prostate tissue, and we chart the timing of those changes in the diseases history through amalgamation of several previously published data sets. We also review associations with genetic alterations and hormone signalling, before the practicalities of investigating prostate cancer methylation using cell lines are assessed. We conclude by outlining the interplay between DNA methylation and prostate cancer metabolism and their regulation by androgen receptor, with a specific discussion of the mitochondria and their associations with DNA methylation.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Biomarkers; Epigenetic; Metabolism; Methylation; Mitochondria; Prostate cancer

Mesh:

Substances:

Year:  2016        PMID: 27117390     DOI: 10.1016/j.jsbmb.2016.04.009

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  45 in total

1.  6-gene promoter methylation assay is potentially applicable for prostate cancer clinical staging based on urine collection following prostatic massage.

Authors:  Kostyantyn A Nekrasov; Mark V Vikarchuk; Evgeniya E Rudenko; Igor V Ivanitskiy; Viacheslav M Grygorenko; Rostyslav O Danylets; Alexander G Kondratov; Liubov A Stoliar; Bizhan R Sharopov; Volodymyr I Kashuba
Journal:  Oncol Lett       Date:  2019-10-29       Impact factor: 2.967

2.  A comprehensive methylation signature identifies lymph node metastasis in esophageal squamous cell carcinoma.

Authors:  Roshni Roy; Raju Kandimalla; Fuminori Sonohara; Masahiko Koike; Yasuhiro Kodera; Naoki Takahashi; Yasuhide Yamada; Ajay Goel
Journal:  Int J Cancer       Date:  2018-10-16       Impact factor: 7.396

3.  Tissue-specific DNA methylation loss during ageing and carcinogenesis is linked to chromosome structure, replication timing and cell division rates.

Authors:  Marija Dmitrijeva; Stephan Ossowski; Luis Serrano; Martin H Schaefer
Journal:  Nucleic Acids Res       Date:  2018-08-21       Impact factor: 16.971

Review 4.  Mitochondrial biology and prostate cancer ethnic disparity.

Authors:  Jialin Xiao; Pinchas Cohen; Mariana Carla Stern; Folakemi Odedina; John Carpten; Renee Reams
Journal:  Carcinogenesis       Date:  2018-12-13       Impact factor: 4.944

5.  DNMT1 and DNMT3B regulate tumorigenicity of human prostate cancer cells by controlling RAD9 expression through targeted methylation.

Authors:  Aiping Zhu; Kevin M Hopkins; Richard A Friedman; Joshua D Bernstock; Constantinos G Broustas; Howard B Lieberman
Journal:  Carcinogenesis       Date:  2021-02-25       Impact factor: 4.944

6.  Exercise training as a modulator of epigenetic events in prostate tumors.

Authors:  Suzanne Dufresne; Jordan Guéritat; Carmen P Wong; Amin Isanejad; Emily Ho; Eva Serna; Marie-Carmen Gomez-Cabrera; Amélie Rebillard
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-05-18       Impact factor: 5.554

7.  Expression of UDP Glucuronosyltransferases 2B15 and 2B17 is associated with methylation status in prostate cancer cells.

Authors:  Farideh Shafiee-Kermani; Skyla T Carney; Dereje Jima; Utibe C Utin; LaNeisha B Farrar; Melvin O Oputa; Marcono R Hines; H Karimi Kinyamu; Kevin W Trotter; Trevor K Archer; Cathrine Hoyo; Beverly H Koller; Stephen J Freedland; Delores J Grant
Journal:  Epigenetics       Date:  2020-07-27       Impact factor: 4.528

8.  Distinct DNA methylation patterns associated with treatment resistance in metastatic castration resistant prostate cancer.

Authors:  Madonna R Peter; Misha Bilenky; Alastair Davies; Ruth Isserlin; Gary D Bader; Neil E Fleshner; Martin Hirst; Amina Zoubeidi; Bharati Bapat
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

9.  Dynamic patterns of DNA methylation in the normal prostate epithelial differentiation program are targets of aberrant methylation in prostate cancer.

Authors:  Mark D Long; Vineet K Dhiman; Hayley C Affronti; Qiang Hu; Song Liu; Dominic J Smiraglia
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

10.  A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer.

Authors:  Erik Bovinder Ylitalo; Elin Thysell; Mattias Landfors; Sofie Degerman; Pernilla Wikström; Maria Brattsand; Emma Jernberg; Sead Crnalic; Anders Widmark; Magnus Hultdin; Anders Bergh
Journal:  Clin Epigenetics       Date:  2021-06-30       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.